Alexey V. Danilov M.D., Ph.D.

Photo of Alexey V. Danilov, M.D., Ph.D.
Faculty profile

Associate Professor of Medicine School of Medicine

Accepting new patients

4.9 out of 5 (188 Ratings, 23 Comments)

Expertise

  • Cancer
  • Cancer and Blood Disorders

Special focus on

  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Lymphoma
  • Non-Hodgkin lymphoma

Education

  • M.D., Yaroslavl State Medical Academy, Yaroslavl 1997
  • Ph.D., Yaroslavl State Medical Academy, Yaroslavl 2000
  • Residency:

    • Internal medicine, Brown University School of Medicine, 2007
  • Fellowship:

    • Hematology-oncology, Tufts Medical Center, Boston, 2010
  • Certifications:

    • American Board of Internal Medicine: internal medicine, 2007
    • American Board of Internal Medicine: medical oncology, 2010
    • American Board of Internal Medicine: hematology, 2012

Biography

Dr. Alexey Danilov is a physician with special expertise in lymphoma and chronic lymphocytic leukemia. In addition to taking care of patients with lymphoma and CLL, Dr. Danilov initiates and leads clinical trials and heads a research laboratory which investigates novel therapeutic targets in lymphoma. Importantly, in collaboration with industry, his research team translates bench discoveries into early-phase clinical trials, which are poised to improve lives of patients by developing safe and effective new treatments. Dr. Danilov is a Lymphoma Research Foundation Clinical Investigator and a Knight Research Scholar. He and his research team are recipients of numerous awards, including the Leukemia and Lymphoma Society Translational Research Program Award, American Society of Hematology Abstract Achievement Award, Gazzaniga Family Prize, Professor Albitski Prize and others. His research is consistently featured at national and international meetings.

Dr. Danilov developed new clinical trials which target the tumor-supporting niche; optimized treatment regimens for older patients with CLL; defined novel ways to target the tumor niche in lymphoma and CLL; discovered how novel class of drugs, CDK inhibitors, kill tumor cells.

Read more

Clinical Trials

The following clinical trials are currently accepting new participants:

Search all studies

Patient Ratings

4.9 out of 5 (188 Ratings, 23 Comments)

The patient ratings score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey

  • Friendliness/courtesy 4.9
  • Explanations about your problem/condition 4.9
  • Concern shown for your questions/worries 4.9
  • Effort made to include you in treatment decisions 4.9
  • Used words you could understand 4.9
  • Amount of time spent with you 4.8
  • Your confidence in care provider 4.9
  • Likelihood of recommending to others 4.9
  • Likelihood of recommending to others 4.9

Patient Comments

  • May 29, 2018

    Dr. Danilov's professional yet friendly manner helps be feel more confidence in being able to fight cancer to get a remission from Lymphoma.

  • May 27, 2018

    Dr is very kind, easy to relate to. Gives time for me to ask questions. Seems to genuinely care and concerned.

  • May 09, 2018

    I am vey fortunate to have Dr Danilov for care

  • Apr 09, 2018

    yes I would recommend him

  • Mar 26, 2018

    Having a diagnosis of cancer is frightening. Dr. Danilov's attitude of confidence, professionalism, and optimism made me less afraid.

  • Feb 26, 2018

    felt respected and valued by bith the Fellows Student & the Main Provider.They both listened to me and took time to explain.

  • Dec 18, 2017

    The Best

  • Oct 16, 2017

    always a good expreience

  • May 01, 2017

    I feel better knowing I'm under their care.

  • Mar 06, 2017

    he seemed a bit off today

Make an Appointment

503 494-7999

Physician Referrals

503 494-7999

I see patients at